Medical Devices · Malvern, Pennsylvania, United States
$0.82
-5.68% (-$0.05)2026-07-09
Smart-Money SignalNeutral · 52/100— Insider open-market flow is flat over 90 days
Revenue$19.1M
Net Income-$12.3M
EPS$-0.21
Gross Margin65.7%
Market Cap$36.7M
Price Performance
Historical data including institutional events
Company Profile
A
Antony Koblish
CEO & Executive Director
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patientâs anatomy.
The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.
It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
